Theragenics Corp said it will receive aU.S. patent on its TheraSeed localized radiation therapy fortreatment of prostate cancer, effective June 23.    It said it has obtained product liability insurance forTheraseed and expects commercial sales and distribution tostart by July 15. Reuter&#3;